Texas Bids > Bid Detail
Notice of Intent to Sole Source Xpress, COV-2/Flu/RSV Plus and Xpress, SARS-COV-2 Plus Test Kits
Agency: | VETERANS AFFAIRS, DEPARTMENT OF |
---|---|
Level of Government: | Federal |
Category: |
|
Opps ID: | NBD00159695690251120 |
Posted Date: | May 3, 2023 |
Due Date: | |
Solicitation No: | 36C25723D0038 |
Source: | https://sam.gov/opp/fca31337c5... |
Follow
Active
Contract Opportunity
Notice ID
36C25723D0038
Related Notice
36C25723Q0234
Contract Line Item Number
10
Department/Ind. Agency
VETERANS AFFAIRS, DEPARTMENT OF
Sub-tier
VETERANS AFFAIRS, DEPARTMENT OF
Office
257-NETWORK CONTRACT OFFICE 17 (36C257)
Award Details
General Information
Classification
Description
Contact Information
History
- Contract Award Date: May 02, 2023
- Contract Award Number: 36C25723D0038
- Task/Delivery Order Number: 36C25723N0271
- Contractor Awarded Unique Entity ID: W6HQTMWB9Q28
- Contractor Awarded Name: CEPHEID
- Contractor Awarded Address: Sunnyvale , CA 94089-1189 USA
- Base and All Options Value (Total Contract Value): $1,400,000.00
- Contract Opportunity Type: Award Notice (Original)
- All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
- Original Published Date: May 03, 2023 10:56 am EDT
- Inactive Policy: 15 days after contract award date
- Original Inactive Date: May 17, 2023
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: 6640 - LABORATORY EQUIPMENT AND SUPPLIES
-
NAICS Code:
- 325413 - In-Vitro Diagnostic Substance Manufacturing
-
Place of Performance:
Harlingen , TX 78550USA
-
- Texas Valley Costal Bend Health Care System (TXVCB) has a need for the SARS-COV-2 PLUS and COV-2/FLU/RSV PLUS test kits compatible with the Cepheid Instrumentation. The COVID19 test kits are the only approved FDA Emergency Use Authorization that is exclusively made to work on the current VCB owned Cepheid Analyzers. The SARS CoV-2 and the SARS-CoV-2/Flu/RSV test kits are a rapid, multiplexed real-time RT-PCR test intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) viral RNA in either nasopharyngeal swab, nasal swab or nasal wash/aspirate specimens collected from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider suspected of COVID-19 by their healthcare provider, pursuant to Section 564 of the Federal Food, Drug, and Cosmetic Act (the Act) (21 U.S.C. §360bbb-3). The COVID and COVID/FLU/RSV is for use only under EUA in the United States (U.S.) in laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests.
Attachments/Links
Contracting Office Address
- 2301 E. LAMAR BLVD
- ARLINGTON , TX 76006
- USA
Primary Point of Contact
- Melanie Williams
- melanie.williams5@va.gov
- Phone Number 210-694-6378
Secondary Point of Contact
- May 03, 2023 10:56 am EDTAward Notice (Original)
- Jan 11, 2023 11:58 pm EST Special Notice (Inactive)
TRY FOR FREE
Not a USAOPPS Member Yet?
Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.